US 8481599
Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism
granted A61KA61K31/13A61K31/137
Quick answer
US patent 8481599 (Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism) held by TONIX PHARMACEUTICALS HOLDING CORP expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TONIX PHARMACEUTICALS HOLDING CORP
- Grant date
- Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/13, A61K31/137, A61K31/353, A61K31/445